Efficacy, Tolerability and Adverse Effects of Triple Fixed Dose Combination Brimonidine–Brinzolamide–Timolol Ophthalmic Suspension in Primary Open Angle Glaucoma: A Retrospective Study
Purpose: To evaluate the efficacy and tolerability of recently introduced triple fixed dose combination (TFC) of brimonidine–brinzolamide–timolol (BBTFC) in patients with primary open angle glaucoma (POAG). Materials and Methods: A retrospective review was done in POAG patients who were shifted to t...
Saved in:
| Main Authors: | Hina Kounsar, Swati Singh, Harsh Kumar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/DLJO.DLJO_54_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Experience with Timolol and Brinzolamide Fixed-combination: A Case Series
by: S. V. Yanchenko, et al.
Published: (2025-06-01) -
Experience in Application of the Combinations Dorzolamide / Timolol and Brinzolamide / Timolol for the Prevention of Intraocular Hypertension in Patients with Silicone Oil Tamponade of the Vitreal Cavity
by: A. N. Kazennov, et al.
Published: (2024-10-01) -
Adjunctive antihypertensive therapy of primary glaucoma with a fixed combination drug of 1% brinzolamide and 0.5% timolol: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2023-07-01) -
Timolol versus latanoprost for primary open-angle glaucoma
by: Nilo Vincent dG. FlorCruz II, MD, et al.
Published: (2005-06-01) -
Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment
by: Haroon Iqbal, et al.
Published: (2025-10-01)